1. Home
  2. WLDS vs KTTA Comparison

WLDS vs KTTA Comparison

Compare WLDS & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$1.26

Market Cap

19.7M

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$1.12

Market Cap

5.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
KTTA
Founded
2014
2020
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
5.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
WLDS
KTTA
Price
$1.26
$1.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
741.3K
17.5M
Earning Date
12-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.28
52 Week High
$11.40
$3.85

Technical Indicators

Market Signals
Indicator
WLDS
KTTA
Relative Strength Index (RSI) 29.54 55.73
Support Level $1.34 $1.02
Resistance Level $1.71 $1.21
Average True Range (ATR) 0.15 0.09
MACD -0.01 -0.01
Stochastic Oscillator 2.07 33.62

Price Performance

Historical Comparison
WLDS
KTTA

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: